Evidence map›Paper›PMID 35741733›Full record

ArticleGenes2022

Genetic Alterations, DNA Methylation, Alloantibodies and Phenotypic Heterogeneity in Type III von Willebrand Disease.

Muhammad Asif Naveed, Aiysha Abid, Nadir Ali, Yaqoob Hassan, Ali Amar, Aymen Javed, Khansa Qamar, Ghulam Mustafa, Ali Raza, Umera Saleem and 4 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Muhammad Asif NaveedDepartment of Haematology, University of Health Sciences, Khayaban Jamia Punjab, Lahore 52600, Pakistan.ORCID 0000-0002-4941-0153
Aiysha AbidCentre for Human Genetics and Molecular Medicine, Sindh Institute of Urology Transplantation, Karachi 42000, Pakistan.ORCID 0000-0001-8977-7315
Nadir AliKulsoom International Hospital, 2020 Jinnah Ave, G 6/2 Blue Area, Islamabad 53000, Pakistan.
Yaqoob HassanChughtai's Lahore Lab, 42300 Jail Road, Lahore 52600, Pakistan.
Ali AmarHuman Genetics and Molecular Biology, University of Health Sciences, Khayaban Jamia Punjab, Lahore 52600, Pakistan.ORCID 0000-0002-3240-0741
Aymen JavedDepartment of Obstetrics and Gynaecology Services Hospital Jail Road, Lahore 42500, Pakistan.
Khansa QamarDepartment of Haematology, University of Health Sciences, Khayaban Jamia Punjab, Lahore 52600, Pakistan.
Ghulam MustafaDepartment of Haematology, University of Health Sciences, Khayaban Jamia Punjab, Lahore 52600, Pakistan.
Ali RazaCentre for Human Genetics and Molecular Medicine, Sindh Institute of Urology Transplantation, Karachi 42000, Pakistan.ORCID 0000-0001-9765-8818
Umera SaleemDepartment of Pathology, Nishter Medical University, Nishter Road, Multan 32003, Pakistan.
Shabbir HussainDepartment of Biochemistry, University of Health Sciences, Khayaban Jamia Punjab, Lahore 52600, Pakistan.
Madiha ShakoorHuman Genetics and Molecular Biology, University of Health Sciences, Khayaban Jamia Punjab, Lahore 52600, Pakistan.
Shagufta KhaliqHuman Genetics and Molecular Biology, University of Health Sciences, Khayaban Jamia Punjab, Lahore 52600, Pakistan.
Shahida MohsinDepartment of Haematology, University of Health Sciences, Khayaban Jamia Punjab, Lahore 52600, Pakistan.
University of Health Sciences Lahore · PKSindh Institute of Urology and Transplantation · PKNishtar Medical College and Hospital · PKServices Hospital · PKShifa International Hospital · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type III von Willebrand disease is present in the Punjab province of Pakistan along with other inherited bleeding disorders like hemophilia. Cousin marriages are very common in Pakistan so genetic studies help to establish protocols for screening, especially at the antenatal level. Factors behind the phenotypic variation of the severity of bleeding in type III vWD are largely unknown. The study was conducted to determine Mutations/genetic alterations in type III von Willebrand disease and also to determine the association of different mutations, methylation status, ITGA2B/B3 mutations and alloimmunization with the severity of type III vWD. After informed consent and detailed history of the patients, routine tests and DNA extraction from blood, mutational analysis was performed by Next Generation Sequencing on Ion Torrent PGM. DNA methylation status was also checked with the help of PCR. In our cohort, 55 cases were detected with pathogenic mutations. A total of 27 different mutations were identified in 55 solved cases; 16 (59.2%) were novel. The mean bleeding score in truncating mutations and essential splice site mutations was relatively higher than weak and strong missense mutations. The mean bleeding score showed insignificant variation for different DNA methylation statuses of the

Indexed as

von Willebrand Diseasesvon Willebrand Disease, Type 3DNA MethylationFemaleHemorrhageHumansIsoantibodiesMutationPhenotypePregnancyvon Willebrand FactorIsoantibodiesvon Willebrand Factormethylationmutationsphenotypic heterogeneityvon Willebrand diseasevon Willebrand factor

Identifiers

PMID35741733
PMCPMC9222927
OpenAlexW4281699447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.